MC3482 B

CAS No. 2922280-86-0

MC3482 B( —— )

Catalog No. M33011 CAS No. 2922280-86-0

MC3482 is a specific inhibitor of sirtuin5 (SIRT5).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 Get Quote
5MG 107 Get Quote
10MG 180 Get Quote
25MG 273 Get Quote
50MG 431 Get Quote
100MG 686 Get Quote
500MG 1377 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MC3482 B
  • Note
    Research use only, not for human use.
  • Brief Description
    MC3482 is a specific inhibitor of sirtuin5 (SIRT5).
  • Description
    MC3482 is a specific sirtuin5 (SIRT5) inhibitor.
  • In Vitro
    MC3482 inhibits sirtuin5. 50 μM MC3482 inhibits SIRT5 desuccinylating activity without affecting SIRT5 intracellular expression levels. Autophagy and mitophagy increase in SIRT5-silenced cells and in WT cells treated with MC3482 and decrease in SIRT5-overexpressing cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    Sirtuin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2922280-86-0
  • Formula Weight
    618.68
  • Molecular Formula
    C33H38N4O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 130 mg/mL (210.12 mM)
  • SMILES
    [C@H](C(NC1=CC=CC=C1)=O)(NC(OCC2=CC=CC=C2)=O)CCCCNC(CC[C@H](NC(OCC3=CC=CC=C3)=O)C(O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Polletta L, et al. SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy. 2015;11(2):253-70.?
molnova catalog
related products
  • YK-3-237

    A novel small molecule sirtuin-1 (SIRT1) activator that reduces acetylation of mutant 53 and exhibits anti-proliferative effects against TNBC cells carrying mutant p53.

  • MZ-242

    A novel potent, selective Sirt2 inhibitor with IC50 of 0.118 uM.

  • SirT1 enhancer A03

    SirT1 enhancer A03 is a specific, orally bioavailable, brain penetrant apolipoprotein E4 (ApoE4)-targeted sirtuin1 (SirT1) enhancer.